Table of Contents
Biologic License Application STN BL 125036 - Biogen Alefacept for the Treatment of Chronic Plaque Psoriasis
Alefacept BLA Review Committee
Alefacept
The Interaction Between T Cells and Antigen-Presenting Cells
Alefacept: Mechanism of Action (1)
Alefacept: Mechanism of Action (2)
CD2 Expression
Alefacept - Biogen (STN BL 125036)
|
Author: E.Bonvini
|